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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 99 (FGE.99): 
Consideration of furanone derivatives evaluated by the JECFA (63rd, 65th 
and 69th meetings)1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to consider evaluations of flavouring substances assessed since 
2000 by the Joint FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide 
whether further evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. 
The present consideration concerns a group of five furanone derivatives evaluated by the JECFA at 
their 63rd, 65th and 69th meetings. The substances were evaluated through a stepwise approach that 
integrates information on structure-activity relationships, intake from current uses, toxicological 
threshold of concern, and available data on metabolism and toxicity. The Panel agrees with the 
application of the Procedure as performed by the JECFA for one of the five substances [FL-no: 
13.010]. Contrary to the JECFA the Panel allocate three substances [FL-no: 13.084, 13.085 and 
13.099] to structural class III due to lack of information on natural occurrence. With regards to the 
substance [FL-no: 13.176] for which the JECFA concluded that the Procedure for the Safety 
Evaluation of Flavouring Agents could not be applied because of the unresolved toxicological 
concerns relating to the epoxidation and opening of the furan ring, the Panel concluded that adequate 
NOAELs exist and accordingly concluded, “No safety concern at the estimated level of intake”. 
Therefore, the Panel concluded that all five substances do not give rise to safety concern at their levels 
of dietary intake, estimated on the basis of the MSDI approach. Besides the safety assessment of these 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-2007-00577, EFSA-Q-2007-00594, EFSA-Q-2007-00595, 
EFSA-Q-2007-00597 and EFSA-Q-2007-00608 adopted on 27 September 2012. 
2  Panel members: Ulla Beckman Sundh, Mona-Lise Binderup, Leon Brimer, Laurence Castle, Karl-Heinz Engel, Roland 
Franz, Nathalie Gontard, Rainer Gürtler, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean Claude Lhuguenot, 
Wim Mennes, Maria Rosaria Milana, Iona Pratt, Kettil Svensson, Maria de Fatima Tavares Poças, Fidel Toldra, Detlef 
Wölfle. Correspondence: cef@efsa.europa.eu. 
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Flavourings for the preparation of 
this Opinion: Ulla Beckman Sundh, Vibe Beltoft, Leon Brimer, Wilfried Bursch, Angelo Carere, Karl-Heinz Engel, 
Henrik Frandsen, Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard 
Mulder, Karin Nørby, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the preparatory 
work on this scientific Opinion. 
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flavouring substances, the specifications for the materials of commerce have also been considered and 
for all five substances, the information is adequate. 
© European Food Safety Authority, 2012 
KEY WORDS 
Furanone derivatives, flavourings, food safety, JECFA, 63rd meeting, 65th meeting, 69th meeting, 
FGE.99 
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SUMMARY  
The European Food Safety Authority (EFSA) asked the Scientific Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission 
on the implications for human health of chemically defined flavouring substances used in or on 
foodstuffs in the Member States In particular, the Panel was requested to consider the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA) evaluations of flavouring substances 
assessed since 2000, and to decide whether no further evaluation is necessary, as laid down in 
Commission Regulation (EC) No 1565/2000. These flavouring substances are listed in the Register, 
which was adopted by Commission Decision 1999/217/EC and its consecutive amendments. 
This consideration deals with five furanone derivatives, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-
no: 13.010], 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084], 4-hydroxy-5-methylfuran-
3(2H)-one [FL-no: 13.085], 4-acetoxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.099] and furaneyl 
butyrate [FL-no: 13.176], which are in the Register and which were evaluated by the JECFA at its 
63rd, 65th and 69th meetings. 
The Panel concluded that no supporting Flavouring Group Evaluation (FGE) was available for the 
substances in the present FGE.  
The Panel agrees with the application of the Procedure as performed by the JECFA for only one 
substance [FL-no: 13.010] considered in this FGE. The JECFA stated that the three substances [FL-no: 
13.084, 13.085 and 13.099] belong to structural class II, but as data on natural occurrence are not 
available for these three substances, the Panel disagree with this and allocate these three substances to 
structural class III. In addition, for the substance [FL-no: 13.176] the JECFA concluded that the 
Procedure for the Safety Evaluation of Flavouring Agents could not be applied because of the 
unresolved toxicological concerns relating to the epoxidation and opening of the furan ring. The Panel 
disagreed with the conclusions by the JECFA and regarded this substance to be sufficiently 
structurally related to the other substances in this group. 
The Panel concluded that there is no safety concern for the candidate substances in this FGE, based on 
the MSDI approach. 
For all substances evaluated through the Procedure use levels are needed to calculate the modified 
Theoretical Added Maximum Daily Intake (mTAMDI) in order to identify those flavouring substances 
that need more refined exposure assessment and to finalise the evaluation. 
In order to determine whether the conclusion for the JECFA evaluated substances can be applied to the 
materials of commerce, it is necessary to consider the available specifications. Adequate specifications 
including complete purity criteria and identity tests are available for all the JECFA evaluated 
substances. 
Thus, for all five substances [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176] the Panel concluded 
that they would be of “no safety concern at estimated levels of intake as flavouring substances” based 
on the MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a).  
Commission Regulation (EC) No 1565/2000 lays down that substances that are contained in the 
Register and will be classified in the future by the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) so as to present no safety concern at current levels of intake will be considered 
by the European Food Safety Authority (EFSA), who may then decide that no further evaluation is 
necessary. 
In the period 2000 - 2008, during its 55th, 57th, 59th, 61st, 63rd, 65th, 68th and 69th meetings, the JECFA 
evaluated about 1000 substances, which are in the EU Register. 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to consider the JECFA evaluations of 
flavouring substances assessed since 2000, and to decide whether no further evaluation is necessary, as 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a). These flavouring substances 
are listed in the Register which was adopted by Commission Decision 1999/217 EC (EC, 1999a) and 
its consecutive amendments. The evaluation programme was finalised at the end of 2009. 
The Commission requested EFSA, based on additional submitted data on genotoxicity, to carry out a 
re-evaluation of the flavouring substance, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010], 
and depending on the outcome, to proceed to the evaluation of these flavouring substances through the 
Procedure, also according to Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), hereafter named the “EFSA Procedure”. 
This Procedure is based on the Opinion of the Scientific Committee on Food (SCF, 1999a), which has 
been derived from the evaluation Procedure developed by the Joint FAO/WHO Expert Committee on 
Food Additives (JECFA, 1995; JECFA, 1996a; JECFA, 1997a; JECFA, 1999b), hereafter named the 
“JECFA Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (the Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
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In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006c). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 microgram per 
person per day would not be expected to present a safety concern. The Committee recommended that 
the Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be 
amended to include the last step on the right-hand side of the original procedure (“Do the condition of 
use result in an intake greater than 1.5 microgram per day?”)” (JECFA, 1999b).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 microgram per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999a), the Panel has in its evaluation focussed on a 
possible genotoxic potential of the flavouring substances or of structurally related substances. 
Generally, substances for which the Panel has concluded that there is an indication of genotoxic 
potential in vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are 
provided. Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated 
through the Procedure. 
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Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE 
The five furanone derivatives [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176] were originally 
members of a group of 58 substances evaluated by the JECFA at their 63rd, 65th and 69th meetings 
(JECFA, 2005c; JECFA, 2006b; JECFA, 2009c) and discussed by EFSA in FGE.75 (EFSA, 2008aw). 
The Panel concluded that these five substances are structurally different to the other substances in 
FGE.75 and therefore these five substances will be considered in a separate FGE (FGE.99). As the 
five candidate substances are α,β-unsaturated ketones they have been considered together with other 
α,β-unsaturated substances with respect to genotoxicity in FGE.220Rev1(EFSA, 2011a). The Panel 
concluded that the data available ruled out the concern for genotoxicity and thus concluded that these 
five substances can be evaluated through the Procedure. 
1. Presentation of the Substances in the JECFA Flavouring Group 
1.1. Description 
1.1.1. JECFA Status 
The JECFA has at the 63rd meeting evaluated a group of 18 flavouring substances consisting of 
tetrahydrofuran and furanone derivatives (JECFA, 2005c). 
The JECFA has at the 65th meeting evaluated a group of 40 furan-substituted aliphatic hydrocarbons, 
alcohols, aldehydes, ketones, carboxylic acids and related esters, sulphides, disulphides and ethers 
(JECFA, 2006b) where a request for additional data was expressed. The furan group was on the 
agenda again at the 69th JECFA meeting (JECFA, 2009c) where additional data had been provided. 
1.1.2. EFSA Considerations  
This FGE only deals with five of the above mentioned 58 substances, four substances evaluated by the 
JECFA at the 63rd meeting [FL-no: 13.010, 13.084, 13.085, 13.099] and one substance evaluated by 
the JECFA at the 65th meeting [FL-no: 13.176]. They are all furanone derivatives and the Panel 
concluded that these substances should be considered in a separate group. 
Accordingly five substances [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176] will be considered in 
the present FGE. 
1.2. Isomers 
1.2.1. Status 
Four substances in the present group of furanone derivatives have one chiral centre. 
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1.2.2. EFSA Considerations 
Adequate information on isomeric composition is available for all the candidate substances in FGE.99. 
1.3. Specifications 
1.3.1. JECFA Status 
The JECFA specifications are available for all five substances (JECFA, 2005b; JECFA, 2005d) (see 
Table 1). 
1.3.2. EFSA Considerations 
The available specifications are considered adequate for all five candidate substances in FGE.99 (See 
Section 1.2 and Table 1). 
2. Intake Estimations 
2.1. JECFA Status 
For all substances evaluated through the JECFA Procedure, intake data are available for the EU.  
2.2. EFSA Considerations 
Tonnage data are available for the EU allowing calculation of the intake estimates (MSDI). The Panel 
noted that since no use levels were submitted no mTAMDI values can be calculated. 
3. Genotoxicity Data 
3.1. Genotoxicity Studies – Text Taken4 from the JECFA (JECFA, 2006a) 
In vitro 
4-Hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] (10 - 12,0005 µg/plate), 4-hydroxy-2,5-
dimethylfuran-3(2H)-one [FL-no: 13.010] (10 - 10,000 µg/plate), and 2-ethyl-4-hydroxy-5-methyl-
3(2H)-furanone [FL-no: 13.084] (up to 10,000 µg/plate) induced reverse mutations in standard and 
modified Ames assays. Positive results were obtained for 4-hydroxy-2,5-dimethylfuran-3(2H)-one 
[FL-no: 13.010] in Salmonella typhimurium strains TA100, TA102, TA98 and TA97 at the highest 
dose tested (4000 µg/plate) with or without metabolic activation (Xing et al., 1988). In contrast, 
(Gilroy et al., 1978) and (Hiramoto et al., 1996b) reported positive results for this compound only in S. 
typhimurium strain TA100 when tested at concentrations of ≤ 10,000 µg/plate with or without 
metabolic activation. Similarly, 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084] and 4-
hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] produced positive results in S. typhimurium strain 
TA100 with or without metabolic activation (Hiramoto et al., 1996a; Li et al., 1998). 
The standard Rec assay with Bacillus subtilis H17 (rec+) and M45 (rec-) exposed to 4-hydroxy-2,5-
dimethylfuran-3(2H)-one [FL-no: 13.010] at a concentration of 20, 40, 60, 80 and 120 µg/disc yielded 
a dose-dependent DNA damage response (Xing et al., 1988). 
                                                     
 
4 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
5 Maximum concentration tested with [FL-no: 13.085] could not be verified in the publications cited by JECFA (2006a). These publications mention a 
maximum concentration of 5000 µg/plate, which has been mentioned in the tables in this FGE. 
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In vivo 
In an assay for genotoxicity in vivo, groups of five ICR mice were given a negative control, or 4-
hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] or 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanon 
[FL-no: 13.084] at a concentration of 1000, 2000 or 3000 mg/kg bw by oral administration. Blood was 
drawn at intervals of 15 min. after administration for up to 120 min. For 4-hydroxy-2,5-dimethylfuran-
3(2H)-one, the frequency of micronucleated peripheral reticulocytes was increased at a dose of 2000 
and 3000 mg/kg bw, but not at 1000 mg/kg bw. For 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanon, the 
frequency was increased at all three doses (Hiramoto et al., 1998). Kunming mice injected 
intraperitoneally with 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] at a dose of 0, 186, 
232 or 309 mg/kg bw demonstrated a dose-dependent increase in erythrocyte micronucleus formation 
in the bone marrow, reaching a maximum increase of 2.6-fold (Xing et al., 1988). Also male mice 
injected with 4-hydroxy-2,5-dimethylfuran-3(2H)-one at a dose of 0, 232, 464 or 928 mg/kg bw 
exhibited increases in spermatocyte chromosome aberrations (Xing et al., 1988). In a similar assay in 
male Kunming mice given 4-hydroxy-2,5-dimethylfuran-3(2H)-one at a dose of 200, 400 or 800 
mg/kg bw by intragastric instillation, a significant increase in sister chromatid exchanges in 
spermatogonial cells compared to controls was reported at all three doses (Tian et al., 1992). Positive 
results were also obtained in an assay for micronucleus formation in male mice given 4-hydroxy-2,5-
dimethylfuran-3(2H)-one at a dose of 200, 400 or 800 mg/kg bw by intraperitoneal injection (Tian et 
al., 1992). The increases observed at each dose did not establish a clear dose–response relationship, 
although increases were significantly higher than for the negative control.  
Groups of five or six male ICR mice were given 4-hydroxy-2,5-dimethylfuran-3(2H)-one at a dose of 
0, 500, 1000 or 1500 mg/kg bw by intraperitoneal injection. Blood samples were drawn at 24, 48 and 
72 hours after injection. The frequency of micronucleated peripheral erythrocytes was significantly 
increased at ≥ 500 mg/kg bw, with the maximum frequency of 1.6 % being obtained at 48 hours after 
dosing (Hiramoto et al., 1996b). 
Groups of five or six male ICR mice were given 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 
13.084] at a dose of 500, 1000 or 1500 mg/kg bw by intraperitoneal injection and samples of 
peripheral blood were taken at 24, 48 and 72 hours after injection. All the mice in the group given 2-
ethyl-4-hydroxy-5-methyl-3(2H)-furanone at a dose of 1500 mg/kg bw died before 24 hours. The 
frequency of micronucleated peripheral erythrocytes was significantly higher than that in the controls 
in groups given 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone at a dose of 500 or 1000 mg/kg bw. The 
maximum number of micronucleated peripheral erythrocytes was observed at 48 hours at 1000 mg/kg 
bw group (0.58 %) and at 500 mg/kg bw (approximately 0.3 %). The frequency of micronucleated 
peripheral erythrocytes reported in mice given the positive control substance, mitomycin C, at a dose 
of 1 mg/kg bw, was 3.1 % (Li et al., 1998). 
In summary, positive results were obtained in several assays for genotoxicity in vivo in mice given 4-
hydroxy-2,5-dimethylfuran-3(2H)-one via intraperitoneal injection at doses as low as 196 mg/kg bw 
(Xing et al., 1988). Similarly, positive results were also obtained for 4-hydroxy-2,5-dimethylfuran-
3(2H)-one administered orally; however, there are conflicting data pertaining to the lowest dose at 
which 4-hydroxy-2,5-dimethylfuran-3(2H)-one elicits a positive response: 200 mg/kg bw according to 
(Tian et al., 1992); ≥ 2000 mg/kg bw according to (Hiramoto et al., 1998). 
Putative mechanism of genotoxicity of furanone derivatives 
 
Furanones induce DNA damage in vitro by generating free radicals that induce strand scission. In the 
presence of metals (e.g. Fe3+) and dissolved oxygen, the enolic hydroxyl group (OH) of the furanone is 
oxidized by single electron transfer to yield the corresponding carbon-centred radical and a reduced 
metal ion (e.g. Fe2+). The carbon-centred radical can couple to molecular oxygen to produce a peroxyl 
radical that may damage DNA. Alternately, the reduced metal ion can auto-oxidize to form a 
superoxide radical anion. The superoxide radical then dismutates into hydrogen peroxide (H2O2). It is 
well recognized that reduced metals react with H2O2 to form a hydroxyl radical, which is a powerful 
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oxidizing agent (see Figure 1). Hydrogen peroxide also oxidizes glutathione leading to decreased 
glutathione S-transferase/oxidized glutathione and an increase in cellular oxidative stress. 
 
OHHO
Fe+++ O2
OO
Fe++ O2-.
O2-.
superoxide
dismutase
H2O2 OH
hydroxy radical,
DNA strand breaking
 
Figure 1 Mechanism of oxidation of furanone derivatives in vitro. 
In the case of 4-hydroxy-2,5-dimethylfuran-3(2H)-one, experimental evidence for this H2O2-
producing pathway includes the following: 
—Fe3+ or Cu2+ is readily reduced to Fe2+ or Cu+ in the presence of 4-hydroxy-2,5-dimethylfuran-
3(2H)-one; 
—DNA strand-breaking of super coiled plasmid DNA into an open circular form in the presence of 4-
hydroxy-2,5-dimethylfuran-3(2H)-one is inhibited in the presence of superoxide dismutase and 
catalase, enzymes used to detoxicate superoxide to form oxygen and water; 
—hydroxyl radical scavengers such as potassium iodine, sodium azide, or ethanol also inhibit DNA 
strand-breaking; 
—free radical spin-trapping agents (e.g. 5,5-dimethyl-1-pyrroline N-oxide) also inhibit DNA strand-
breaking; 
—oxygen radical trapping agents such as 2-mercaptoethanol and cysteine are also inhibitory; 
—removal of dissolved oxygen by nitrogen purge decreases DNA strand-breaking and H2O2 
formation; 
—addition of metal chelating agents also inhibits DNA strand-breaking by depleting the metal ions 
required for this process; 
—DNA strand-breaking by 4-hydroxy-2,5-dimethylfuran-3(2H)-one was much faster in the presence 
of Fe3+ than in its absence; and 
—electron spin resonance of a solution of 4-hydroxy-2,5-dimethylfuran-3(2H)-one and 5,5-dimethyl-
1-pyrroline N-oxide showed the presence of hydroxyl radicals and bicarbonate radicals (Hiramoto et 
al., 1996a; Hiramoto et al., 1996b; Yamashita et al., 1998). 
On the basis of these observations, cellular oxidative stress is related to the dose-dependent oxidation 
of 4-hydroxy-2,5-dimethylfuran-3(2H)-one and structurally related furanones, yielding H2O2 and 
eventually hydroxyl radicals (Hiramoto et al., 1996a; Hiramoto et al., 1996b; Li et al., 1998; 
Yamashita et al., 1998).  
The ability of 4-hydroxy-2,5-dimethylfuran-3(2H)-one to induce oxygen radical formation and DNA 
strand breaks is reminiscent of similar activities observed for vitamin C. Vitamin C (ascorbic acid) 
contains an enediol that is superficially related to the enol of 4-hydroxy-2,5-dimethylfuran-3(2H)-one. 
Being both an enol ether and an αβ-unsaturated ketone, 4-hydroxy-2,5-dimethylfuran-3(2H)-one is 
Flavouring Group Evaluation 99
 
EFSA Journal 2012;10(10):2901 11
subject to hydrolytic ring opening, to yield an enediol. Like 4-hydroxy-2,5-dimethylfuran-3(2H)-one, 
vitamin C also reduces metal ions and produces superoxide anions to generate hydroxyl radicals that 
cleave DNA. As anticipated, vitamin C exhibits genotoxicity in test systems similar to those in which 
furanones give positive results. In standard Ames assays, ascorbic acid (vitamin C) induces reverse 
mutations in S. typhimurium strains TA104, TA102, TA100 and TA98 at concentrations of 352 - 
1761µg/plate (Ichinotsubo et al., 1981b; D’Agostini et al., 2000). In the E. coli Mutoxitest, positive 
results were obtained when ascorbic acid at a concentration of 200, 300 or 400 µg/plate in the 
presence of Cu2+ was incubated with E. coli strain IC203 (Martinez et al., 2000). E. coli IC203 carries 
an oxyR mutation that effectively removes its ability to turn on the biosynthesis of H2O2-protective 
proteins and makes the strain sensitive to DNA damage under conditions of oxidative stress (Blanco et 
al., 1998). 
Increased frequencies of micronucleus formation were observed when ascorbic acid (400, 500 or 600 
µg/ml) was incubated with Chinese hamster cells (Miller et al., 1995). An increase in sister chromatid 
exchanges was observed in Chinese hamster ovary cells in the presence of ascorbic acid at 500 µg/ml 
without metabolic activation (Tennant et al., 1987). In a standard assay for micronucleus formation in 
mice, ascorbic acid at a dose of 1500 mg/kg bw induced a significant increase (Shelby et al., 1993). 
Conclusion 
Furanones are a class of substances present naturally in food and are also added as flavouring agents. 
The principal furanone used as a flavouring agent is 4-hydroxy-2,5-dimethylfuran-3(2H)-one. In 
humans, 4-hydroxy-2,5-dimethylfuran-3(2H)-one is rapidly absorbed in the gastrointestinal tract and 
conjugated with glucuronic acid in the liver. Free 4-hydroxy-2,5-dimethylfuran-3(2H)-one is not 
detected in the blood of human volunteers to whom it is administered as a constituent of strawberries; 
its glucuronic acid conjugate is the principal urinary metabolite (Roscher et al., 1997). Thus, the 
potential for chemical reaction of 4-hydroxy-2,5-dimethylfuran-3(2H)-one with important cellular 
macromolecules, especially DNA, appears to be low.  
Genotoxicity with 3-(2H)-furanone derivatives, notably 4-hydroxy-2,5-dimethylfuran-3(2H)-one and 
2-ethyl-4-hydroxy-5-methyl-3-(2H)-furanone, was observed in standardized bacterial (Gilroy et al., 
1978; Xing et al., 1988; Hiramoto et al., 1996a; Hiramoto et al., 1996b; Li et al., 1998) and 
mammalian assays (Xing et al., 1988; Tian et al., 1992; Hiramoto et al., 1996b). A mechanism for 
genotoxicity involving dose-dependent formation of H2O2 and oxidized furanones has been 
extensively studied (Hiramoto et al., 1995; Hiramoto et al., 1996a; Hiramoto et al., 1996b); these 
studies indicate that, at high doses, DNA single-strand breaks result from the reaction of hydroxyl 
radicals with DNA.  
Despite the fact that 4-hydroxy-2,5-dimethylfuran-3(2H)-one causes genotoxicity, it is not 
carcinogenic in rats. Two studies, one with 4-hydroxy-2,5-dimethylfuran-3(2H)-one and the other with 
a structurally related furanone, showed no evidence of carcinogenicity at intakes that are orders of 
magnitude greater than the intake of furanones added as flavouring agents (Munday and Kirkby, 1973; 
Kelly and Bolte, 2003). Furthermore, vitamin C, a structurally similar compound with a genotoxicity 
test profile similar to that of 4-hydroxy-2,5-dimethylfuran-3(2H)-one, does not demonstrate 
carcinogenicity (National Research Council, 1996). In a 2-year bioassay, the NOEL for 4-hydroxy-
2,5-dimethylfuran-3(2H)-one was 200 mg/kg bw per day in rodents. This intake is approximately 2000 
times higher than the daily per capita intake (‘eaters only’) of 0.088 mg/kg bw per day from use of 4-
hydroxy-2,5-dimethylfuran-3(2H)-one as a flavouring agent. 
After consideration of all the available data, the Committee concluded that it is highly unlikely that 4-
hydroxy-2,5-dimethylfuran-3(2H)-one, other furanones or tetrahydrofurans, would pose any 
significant genotoxic risk to humans under the conditions of use as flavouring agents. Similarly, 2-
ethyl-4-hydroxy-5-methyl-3(2H)-furanone was considered not to pose a genotoxic risk. 
EFSA Conclusion on genotoxicity assessment by the JECFA 
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The Panel notes the mechanism identified by the JECFA and agrees that the positive results obtained 
in genotoxicity studies for these studies are likely to be due to the formation of reactive oxygen 
species. However, the Panel concluded that the possibility of genotoxicity in germ cells had not been 
excluded and in FGE 220 (EFSA, 2009ae), the Panel requested further studies from Industry on germ 
cell genotoxicity. Further studies were submitted by Industry and reviewed by the panel in FGE. 
220Rev 1 (EFSA, 2011a). The Panel’s conclusions on these studies can be found in Section 3.2. 
For a summary of in vitro / in vivo genotoxicity data considered by the JECFA, see Table 2.1 and 2.2. 
There is no relevant text on genotoxicity from the 65th and 69th meetings on the substances in question. 
3.2. Genotoxicity Studies and Conclusion on Genotoxicity and Carcinogenicity - Text taken6 
from FGE.220Rev1 (EFSA, 2011a). 
The following text is relevant for all five substances [FL-no: 13.010, 13.084, 13.085, 13.099 and 
13.176] in this FGE. 
Subgroup 4.4b (Furan-3(2H)-ones in which the α,β-double bond can be involved in keto-enol 
tautomerism). 
For three substances, which belong to subgroup 4.4b the following results have been reported: 
4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] 
For 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] publications on in vitro and in vivo 
studies are available. In three studies the potential of the test substance to induce gene mutations in S. 
Typhimurium was studied. The substance was found positive in two valid studies and in one study 
with limited validity. The substance did not cause gene mutations in a valid study in Escherichia coli 
WP2 uvrA-. It was also observed that the substance caused DNA repair in a less relevant bacterial test 
and single strand breaks in purified DNA. 
All in vivo studies provided indications for a genotoxic potential. Two studies showing micronucleus 
formation in peripheral blood cells were considered valid (Hiramoto et al., 1996b; Hiramoto et al., 
1998); in a third study similar evidence but of limited validity was obtained (Xing et al., 1988). The 
latter authors also reported an increase in sister chromatid exchanges (SCE) in mouse bone marrow, 
but the validity of that observation could not be assessed. In addition this endpoint is of questionable 
relevance for the assessment of genotoxicity. 
In addition to the genotoxicity observed in somatic cells, three studies provided evidence for 
genotoxicity in germ cells.  
The evidence of chromosome aberration induction in mouse germ cells provided in the study by Xing 
et al. (1988) is poor because it is essentially based on an increase of premature disjunction of sex 
chromosomes and autosomes at metaphase I. This effect could be considered at most an alert of 
possible subsequent missegregation events; even so, data have been published (Liang and Pacchierotti, 
1988) showing the lack of correlation between univalents at metaphase I and aneuploidy at metaphase 
II.  
Tian et al. (1992) reported an induction of SCE in spermatogonia. Incomplete information is given on 
the experimental protocol. There is a dose-dependent increase of SCE/cell, with each dose group 
significantly higher than the negative control. For these reasons, these data seem to be convincing 
                                                     
 
6 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
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although obtained on a small (3) number of animals/group. The relevance of SCE in spermatogonia as 
an indicator of heritable genetic damage is limited. 
In the same paper Tian et al. (Tian et al., 1992) reported the induction of micronuclei in early sperm 
cells. This test measures the induction of DNA lesions in preleptotene spermatocytes that can lead to 
breaks and fragments several days later, at the first or second meiotic division. The test has not been 
standardised and validated for routine regulatory application, but has been conducted by more than 
one laboratory in the world with consistent results. The study seems adequately performed. Staining 
with Giemsa is not optimal and does not allow to distinguish among phases of spermatid 
differentiation as recommended by the guidelines (Russo, 2000). However, this drawback could hardly 
produce an overestimation of the effect, more likely, if any, an underestimation. 
4-Hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] and 2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone [FL-no: 13.084] 
Reverse mutations were also observed in S. typhimurium TA100, but not TA98 with 4-hydroxy-5-
methylfuran-3(2H)-one [FL-no: 13.085] and with 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-
no: 13.084]. The other strains were not tested. The same substances could induce single strand breaks 
in purified DNA. With 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084] also induction of 
micronuclei in peripheral erythrocytes was observed in two valid in vivo assays. 
Mechanistic Data 
For the substances in subgroup 4.4b also mechanistic studies were carried out with [FL-no: 13.010, 
13.084 and 13.085], all of which were considered valid. These substances were identified as Maillard 
reaction products in soy sauce. When the substance [FL-no: 13.085] was incubated with super coiled 
pBR 322 plasmid DNA, single strand breaks were observed at pH 4.4, but not at pH 7.4. When a spin 
trap was also present, formation of hydroxy radicals together with a carbon-centred radical could be 
demonstrated. Subsequent addition of superoxide dismutase and catalase inhibited the DNA breaking 
showing involvement of hydrogen peroxide. Potassium iodide, mannitol, sodium azide, and ethanol 
were also inhibitory to the DNA breaking showing involvement of hydroxy radicals. Spin trapping 
agents and thiol compounds and metal chelators also effectively inhibited the breaking of DNA 
(Hiramoto et al., 1996a). Similar studies were carried out with [FL-no: 13.010 and 13.084] with the 
same results and it was also demonstrated that these substances are capable of reducing Fe3+ at neutral 
or alkaline pH (Li et al., 1998).  
For validation and study results see Table 2.1 and 2.2. 
Conclusion on Genotoxicity and Carcinogenicity - Text Taken from FGE.220 (EFSA, 2009ae) 
Apart from the negative predictions for the substances in the DTU-NFI MultiCASE model for the 
Ames test, the (Q)SAR models do not seem to generate a reliable and reproducible pattern of 
predictions on the genotoxicity for the substances in this FGE.  
With several substances in subgroup 4.4b [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176], 
indications have been obtained in in vitro studies that the genetic damage they cause is related to the 
generation of reactive oxygen species as a result of redox cycling in combination with metal ions 
present in the media. The valid positive in vivo data were obtained with high dose levels that may be 
anticipated to have exhausted the anti-oxidant capacity of the target cells. This, in combination with 
the absence of carcinogenicity observed in a valid carcinogenicity study in rats with one of the 
substances [FL-no: 13.010], which was tested positive in the genotoxicity assays, takes away a 
concern for genotoxic events resulting in carcinogenicity in somatic cells. 
For two of the studies in which genotoxic effects were observed in germ cells in vivo the studies had 
limited validity and/or address endpoints that may have limited relevance for the assessment of 
genotoxic potential. The Panel noted that a positive result was obtained in a micronucleus study in 
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early sperm cells. However, a micronucleus test does not discriminate between aneuploidy and 
chromosomal breakage. The observed effects in the germ cells could be the result of the 
malsegregation of chromosomes which is generally considered a thresholded event. They may 
alternatively be the result of the (thresholded) generation of reactive oxygen species. 
Conclusion – Text Taken from FGE.220 (EFSA, 2009ae) 
For the substances in subgroup 4.4b [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176], evidence for 
genotoxicity was obtained in vitro and in vivo. Evidence is available from in vitro studies that the 
genotoxicity of the candidate substances in this subgroup may be caused by indirect (threshold) 
mechanisms of action (in particular generation of reactive oxygen species). The concern for 
carcinogenicity is alleviated, since one of the substances, for which positive genotoxicity data in mice 
were obtained, was not carcinogenic in a valid chronic assay in rats. Therefore, no further genotoxicity 
tests in somatic cells are required. However, some evidence was also available that this substance 
might elicit genotoxic effects in germ cells, which theoretically may result in reduced reproductive 
capacity or in inheritable genetic damage. Reduced reproductive capacity and inheritable genetic 
damage are toxicological endpoints which differ from carcinogenicity and therefore, the negative 
results for the carcinogenicity study cannot be used to overrule this concern. Also it is not clear if (and 
if so to what extent) the threshold mechanism mentioned above would be relevant for genotoxic 
effects in the germ cells. Therefore, the Panel concluded that presently these five substances cannot be 
evaluated through the Procedure. 
The Panel recognised that the studies which provided indications for germ cell genotoxicity are of 
limited validity. For that reason a robust GLP-controlled cytogenetic investigation in mouse 
spermatocytes according to the OECD Guideline 483 is requested. 
Additional Data Submitted by Industry 
 
In response to the EFSA request in FGE.220 of a cytogenetic study in mouse spermatocytes (OECD 
TG 483), Industry has submitted the following data: 
 
• 2-Year carcinogenicity bioassay in rats with a substance coded  ST 07 C99 (this is the study 
on [FL-no: 13.010] by Kelly & Bolte, 2003); 
• Oral male fertility study of FURANEOL =  4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 
13.010] (test article code ST17C07) in rats (Sloter, 2008); 
• Oral micronucleus assay in bone marrow cells of the mouse with NEOFURANEOL (no 
identification of this substance is available) (Honarvar, 2008b); 
• Mouse lymphoma (TK) specific locus mutation assay with compound 0478/1 (Ross and 
Harris, 1979a). 
 
Evaluation of Additional Data 
The Panel noted that among the studies submitted by Industry, only the rat fertility study, which 
includes also the analysis of dominant lethals, is considered relevant for the specific EFSA request. 
The 2-year carcinogenicity bioassay in rats by Kelly and Bolte (Kelly and Bolte, 2003) was already 
evaluated by the Panel in the previous version of FGE.220. It was considered as a valid, negative 
study, however not relevant for the evaluation of possibly inheritable damage. Also the mouse bone 
marrow micronucleus assay with neofuraneol (Honarvar, 2008b) and the in vitro mouse lymphoma TK 
assay (Ross and Harris, 1979a) are considered not relevant to clear the concern for possible inheritable 
damage. Furthermore, an adequate identification of the test substance Neofuraneol was not possible, 
due to incomplete reporting. For these reasons these three studies will not be further considered in this 
section. 
Oral Male Fertility Study of 4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] in Rats (Sloter, 
2008) 
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The objective of this study, performed according to ICH Guideline 4.1.1 (ICH, 1996) under GLP, was 
to determine the potential effects of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] on 
mating, fertility and gonadal function in male rats with two separate mating trials. 4-Hydroxy-2,5-
dimethylfuran-3(2H)-one was administered by gavage once daily to three groups of 25 male 
Crl:CD(SD) rats. Dosage levels were 100, 500 and 1000 mg/kg bw/day. A concurrent control group of 
25 males received the vehicle (propylene glycol) on a comparable regimen. The first mating (Phase I), 
following 2 weeks of male administration, using untreated females, was conducted to detect potential 
elicitation of early genotoxic effects on the embryo with reduced risk of test-article related deficiencies 
in mating or fertility. The second mating (Phase II), following 9 weeks of male dose administration, 
was conducted following male exposure throughout a complete spermatogenic cycle using a second 
set of untreated females. 
There was no test-article related mortality noted in this study. A slightly lower mean body-weight gain 
was noted in the 1000 mg/kg/day group when evaluated for the overall treatment period. No test-
article related effects on male reproductive performance were observed at 100, 500 and 1000 
mg/kg/day when males were mated with Phase I or Phase II females. In particular, there were no 
effects on spermatogenic endpoints (mean testicular and epididymal sperm numbers, sperm production 
rate, motility and morphology, reproductive organs or macroscopic findings) at any of the doses 
tested. The mean percentage of sperm with abnormal morphology (separated head and flagellum) was 
slightly higher in the 500 and 1000 mg/kg/day groups; however, this was primarily attributed to a 
single male in the respective groups and therefore not considered test-article related. The number of 
females mated and the number of pregnant females was comparable to controls. Uterine examination 
was performed for both Phase I and Phase II females. The analysis of embryonic data (corpora lutea, 
implantation sites, viable embryos, dead embryos, early resorptions, late resorptions, total resorptions, 
post- and pre-implantation losses) did not reveal dominant lethal effects. The study does not indicate a 
potential of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] to affect male fertility. This 
study can be considered to be equivalent to an OECD 478 Dominant Lethal assay. The dominant lethal 
assay has been recommended as a follow-up study in case of positive results in the OECD TG 483 
(Eastmond et al., 2009). On this basis the Panel considers it acceptable to substitute the requested 
study according to OECD Guideline 483 with the Dominant Lethal test. 
Conclusion on Additional Data 
The results of a valid rat fertility and dominant lethal study have shown that 4-hydroxy-2,5-
dimethylfuran-3(2H)-one is unable to induce both adverse effects on male rat reproductive capacity 
and dominant lethality. On this basis the Panel concludes that for this substance there is no concern for 
its potential to induce heritable genetic damage or adverse effects on male reproductive capacity. 
Accordingly the substances in subgroup 4.4b of FGE.19 [FL-no: 13.010, 13.084, 13.085, 13.099 and 
13.176] can be evaluated using the Procedure.  
For a summary of in vitro / in vivo genotoxicity data considered by EFSA see Table 2.1, 2.2 and 2.3. 
3.3. EFSA Considerations 
The Panel concluded that the positive results observed in the genotoxicity studies on the substances in 
this group were due to the production of reactive oxygen species, potentiated by the presence of metals 
in the cell medium. The resulting DNA damage is only observed once the cell antioxidant capacity has 
been exhausted. This effect is unlikely to occur at the low levels used to flavour foods. A concern for a 
potential to elicit heritable genetic damage was alleviated by the results of a valid rat fertility and 
dominant lethal study which show that 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] is 
unable to induce both adverse effects on male rat reproductive capacity and dominant lethality. On this 
basis the Panel concludes that for this substance and structurally related  substances there is no 
concern for its potential to induce heritable genetic damage or adverse effects on male reproductive 
capacity. Accordingly, available genotoxicity data presented in this FGE do not preclude the 
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evaluation of the substances in subgroup 4.4b of FGE.19 [FL-no: 13.010, 13.084, 13.085, 13.099 and 
13.176] using the Procedure. 
4. Application of the Procedure 
4.1. Application of the Procedure to Five Furanone Derivatives by the JECFA  
According to the JECFA four substances belong to structural class II and one substance [FL-no: 
13.176] to structural class III using the decision tree approach presented by Cramer et al. (Cramer et 
al., 1978). 
One substance from the 65th and 69th meetings (JECFA, 2006b; JECFA, 2006d; JECFA, 2009a; 
JECFA, 2009c) 
For this substance [FL-no: 13.176] the JECFA concluded that the Procedure for the Safety Evaluation 
of Flavouring Agents could not be applied to this group because of the unresolved toxicological 
concerns relating to the epoxidation and opening of the furan ring. 
Four substances from the 63rd meeting (JECFA, 2005c; JECFA, 2006a) 
The JECFA concluded three [FL-no: 13.084, 13.085 and 13.099] of these four furanone derivatives at 
step A3 in the JECFA Procedure, i.e. the substances are expected to be metabolised to innocuous 
products (step 2) and the intakes for the substances are below the thresholds for their structural classes 
(step A3). 
The last substance [FL-no: 13.010] has intake above the threshold of concern for the corresponding 
structural class (step A3); it is not endogenous (step A4), but an adequate NOAEL of 200 mg/kg 
bw/day is available from the two year carcinogenicity study by Kelly and Bolte, 2003 (Kelly and 
Bolte, 2003) that provides an adequate margin of safety (2.7 x 103) from the exposure as a flavouring 
substance (step A5). 
In conclusion, the JECFA evaluated the four substances to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The evaluations of the furanone derivatives are summarised in Table 3.1: Summary of Safety 
Evaluation of Furanone Derivatives. 
4.2. EFSA Considerations  
The Panel agrees only with the application of the Procedure as performed by the JECFA for one 
substance [FL-no: 13.010]. 
The JECFA stated that the three substances [FL-no: 13.084, 13.085 and 13.099] belong to structural 
class II, but as data on natural occurrence are not available for these three subsatnces, the Panel 
disagree with this and allocate these three substances to structural class III. 
With regards to the substance [FL-no 13.176], the Panel disagreed with the conclusions by the JECFA. 
The JECFA put the assessment of this structural class III substance on hold because of concerns for a 
potential for epoxidation and ring opening which may lead to genotoxic activity. The Panel regarded 
this substance to be sufficiently structurally related to the other substances in this group. In FGE. 
220Rev1, the Panel concluded that data available on substances structurally related to all the candidate 
substances in the present FGE demonstrate that these substances do not pose a concern for 
genotoxicity and can be evaluated through the Procedure. 
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Since the exposure estimates (MSDI) for Europe for two substances [FL-no: 13.085 and 13.176] is 
below the threshold for structural class III (i.e. 90 μg/person/day), at step A3 of the Procedure it is 
concluded that these two substances do not pose a safety concern when used as a flavouring substance 
in food.  
For the remaining two substances [FL-no: 13.084 and 13.099] the exposure estimates (MSDI) for 
Europe are above the threshold for structural class III. Since these substances are not endogenous their 
evaluation proceeds to step A5 of the Procedure. At this step the respective exposure estimates (203 
and 400 μg/capita/day) can be compared to the NOAEL of 200 mg/kg bw/day for [FL-no 13.010], 
which is available from the two year carcinogenicity study by Kelly and Bolte (Kelly and Bolte, 
2003). This NOAEL is based on decreases in mean body weights and body weight gains of male 
and female rats exposed to 400 mg 4-hydroxy-2,5-dimethyl-3(2H)-furanone/kg bw/day compared 
to those of the controls in the last part of the study. No neoplasms or non-neoplastic lesions were 
attributed to exposure to 4-hydroxy-5-dimethyl-3(2H)-furanone. Adequate margins of safety of 5.9 
× 104 and 3.0 x 104 can be calculated for [FL no: 13.084] and [FL-no: 13.099], respectively, from 
which it is concluded that these two substances do not pose a safety concern when used as a flavouring 
substance in food. 
Thus the Panel concluded that there is no safety concern for any of the candidate substances in this 
FGE based on the MSDI approach.  
5. Conclusion 
This consideration deals with five flavouring substances [FL-no: 13.010, 13.084, 13.085, 13.099 and 
13.176], which belong to a group of 18 tetrahydrofuran and furanone derivatives and a group of 40 
furan-substituted aliphatic hydrocarbons, alcohols, aldehydes, ketones, carboxylic acids and related 
esters, sulphides, disulphides and ethers evaluated by the JECFA at the 63rd, 65th and 69th meetings.  
The Panel agrees with the application of the Procedure as performed by the JECFA for only one 
substance [FL-no: 13.010] considered in this FGE. The JECFA stated that the three substances [FL-no: 
13.084, 13.085 and 13.099] belong to structural class II, but as data on natural occurrence are not 
available for these three substances, the Panel disagree with this and allocate these three substances to 
structural class III. In addition, for the substance [FL-no: 13.176] the JECFA concluded that the 
Procedure for the Safety Evaluation of Flavouring Agents could not be applied because of the 
unresolved toxicological concerns relating to the epoxidation and opening of the furan ring. The Panel 
disagreed with the conclusions by the JECFA and regarded this substance to be sufficiently 
structurally related to the other substances in this group. 
The Panel concluded that there is no safety concern for the five substances in this FGE, based on the 
MSDI approach. 
For all five substances evaluated through the Procedure use levels are needed to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessment and to finalise the evaluation. 
In order to determine whether the conclusion for the five JECFA evaluated substances can be applied 
to the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests are available for all JECFA 
evaluated substances.  
Thus, for all five substances [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176] the Panel concluded 
that they would be of “no safety concern at estimated levels of intake as flavouring substances” based 
on the MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY  
Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of Furanone Derivatives (JECFA, 2005b; JECFA, 2005d) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
EFSA comments 
13.010 
1446 
4-Hydroxy-2,5-dimethylfuran-3(2H)-
one 
O
OHO  
3174 
536 
3658-77-3 
Solid 
C6H8O3 
128.13 
Insoluble 
Soluble 
n.a. 
78-80 
IR NMR MS 
98 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2012d). 
13.084 
1449 
2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone 
O
OHO  
3623 
 
27538-09-6 
Liquid 
C7H10O3 
142.15 
Soluble 
Soluble 
103 (20 hPa) 
 
IR NMR 
96 % 
1.509-1.514 
1.133-1.143 
 
Racemate (EFFA, 2012d). 
 
13.085 
1450 
4-Hydroxy-5-methylfuran-3(2H)-one O
OHO  
3635 
11785 
19322-27-1 
Solid 
C5H6O3 
114.10 
Soluble 
Soluble 
n.a. 
126-133 
NMR 
97 % 
n.a. 
n.a. 
 
 
13.099 
1456 
4-Acetoxy-2,5-dimethylfuran-3(2H)-
one 
O
OO
O
 
3797 
 
4166-20-5 
Liquid 
C8H10O4 
170.17 
Slightly soluble 
Soluble 
243 
 
IR NMR MS 
95 % 
1.476-1.480 
1.159-1.167 
 
According to JECFA: Min. assay 
value is "85%" and secondary 
components "4-hydroxy-2,5-
dimethyl-3(2H)-furanone". 
Racemate (EFFA, 2012d). 
 
13.176 
1519 
Furaneyl butyrate O
OO
O
 
3970 
 
114099-96-6 
Liquid 
C10H14O4 
198.22 
Insoluble 
Soluble 
287 
 
NMR 
95 % 
1.467-1.473 
1.095-1.103 
 
According to JECFA: Min. assay 
value is "93 %" and secondary 
components "4-Hydroxy-2,5-
dimethylfuran-3-one, butyric acid" 
Register name to be changed to 4-
Butyroxy-2,5-dimethyl-3(2H)-
furanone (EFFA, 2012d)  
CASrn 114099-96-6 to be 
introduced in the Register (EFFA, 
2012d)  
Racemate (EFFA, 2012d). 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
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TABLE 2: GENOTOXICITY DATA  
Table 2.1: GENOTOXICITY (in vitro) EFSA / FGE.220Rev1 (EFSA, 2011a) 
Chemical Name [FL-no]  Test System Test Object  Concentration Reported 
Result  
Reference  Comments e 
4-Hydroxy-2,5-dimethylfuran-3(2H)-
one [13.010] 
Reversed mutation S. typhimurium TA1535, TA1537, 
TA1538,TA100 and TA98 
10.0, 33.3, 100.0, 333.3, 1000, 
2000, 3300, 4000, 6000, 8000 
µg/plate 
Positivea, b (Gilroy et al., 1978) 
 
Valid. Unpublished non-GLP study. 
The report contains sufficient details. 
Result is considered valid. 
Reversed mutation S. typhimurium TA100 and TA98 0 - 10000 µg/plate Positivea, b (Hiramoto et al., 1996b) 
 
Valid. Positive in TA100 (+/– S9); 
negative in TA98 (+/- S9). 
Reversed mutation S. typhimurium TA100, TA102, TA98 
and TA97 
500 - 4000 µg/plate Positivea, c (Xing et al., 1988) 
 
Limited validity. No methodological 
details, but stated to be performed 
according to (Maron and Ames, 
1983). Some  errors reduce the 
trustworthiness of the paper. 
Reversed mutation E. coli WP2 uvrA- 10.0, 33.3, 100.0, 333.3, 1000, 
3300 µg/plate 
Negative (Gilroy et al., 1978) 
 
Valid. Unpublished non-GLP study. 
The report contains sufficient details. 
Result is considered valid. 
DNA damage  B. subtilis H17 (Rec+) and M45 (Rec-) 20, 40, 60, 80, 120 µg/disc Positive (Xing et al., 1988) 
 
Validity cannot be evaluated (Test 
system with low predictive value for 
genotoxicity).  No methodological 
details, but stated to be performed 
according to (Kada et al., 1972). 
DNA strand breaks  pBR322 DNA 2.6 - 780 µmol/l 
(0.3 - 100 mg/l) 
Positive (Hiramoto et al., 1996b) 
 
Valid. Single strand breaks caused by 
redox cycling of the substance in 
combination with metal ions, 
generating reactive oxygen species. 
4-Hydroxy-5-methylfuran-3(2H)-one 
[13.085] 
 
Reversed mutation S. typhimurium TA100 and TA98 0 - 5000 µg/plate Positivea, b (Hiramoto et al., 1996a) 
 
Limited validity. Limited due to 
uncertainty of test substance. 
Positive in TA100 (+/- S9); negative 
in TA98 (+/- S9). 
DNA strand breaks  pBR322 DNA 0 - 900 µmol/l 
(0 - 103mg/l) 
Positivea, d (Hiramoto et al., 1996a) 
 
Valid. Single strand breaks caused by 
redox cycling of the substance in 
combination with metal ions, 
generating reactive oxygen species. 
2,5-Dimethyl-3(2H)-furanone 
[13.119] 
Reverse mutation S. typhimurium TA1535, TA1537, 
TA98,TA100 and TA102,  
0 - 5000 µg/plate Negative (RCC - CCR, 2007) 
 
Valid. According to current 
guidelines. 
2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone [13.084] 
Reversed mutation S. typhimurium TA100 and TA98 0 - 10000 µg/plate Positivea, b (Li et al., 1998) 
 
 Valid. Positive with and without S9 
in TA100; negative in TA98 (+/- S9). 
DNA strand breaks pBR322 DNA 0 - 2000 μM Positived (Li et al., 1998) 
 
Valid. Single strand breaks caused by 
redox cycling of the substance in 
combination with metal ions, 
generating reactive oxygen species. 
a: With and without metabolic activation provided by S9 (9000 x g supernatant from rodent liver). 
b: Positive results only observed in TA100. 
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c: Positive results in all strains at the highest dose tested. 
d: Only positive without inhibitors of redox cycling and ROS scavengers. 
e: Validity of genotoxicity studies: 
 Valid. 
 Limited validity (e.g. if certain aspects are not in accordance with OECD Guidelines or current standards and / or limited documentation). 
 Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
 Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
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Table 2.2: GENOTOXICITY (in vivo) EFSA / FGE.220Rev1 (EFSA, 2011a) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Reported Result  Reference  Comments a
4-Hydroxy-2,5-dimethylfuran-3(2H)-
one [13.010] 
Micronucleus formation Mouse, bone marrow Not stated 0, 186, 232 or 309 mg/kg bw Positive (Xing et al., 1988) 
 
Limited validity. Important data not 
given. Reference to methodological 
description could not be traced. 
Chromosomal aberration Mouse spermatocytes Not stated 0, 232, 464 or 928 mg/kg bw Positive (Xing et al., 1988)) Limited validity. Important data not 
given. Reference to methodological 
description could not be traced. 
Predominant aberration; malsegregation 
of chromosomes. 
Sister chromatid 
exchange 
Mouse, bone marrow Intra-abdominal 
injection 
0, 185, 232, 303 mg/kg Positive (Xing et al., 1988) Validity cannot be assessed. Dose-
related increase; statistically significant 
at all dose levels, but max increase < 2-
fold. Effect not adequately specified; 
very intense exposure to BrdU.  Non-
validated protocol. Relevance for the 
evaluation of genotoxicity questionable. 
Sister chromatid 
exchange 
Mouse spermatocytes Oral (gavage) 200, 400 or 800 mg/kg bw Positive (Tian et al., 1992) 
 
Limited validity. Relevance for the 
evaluation of genotoxicity questionable; 
non-validated test protocol. 
Micronucleus formation Mouse early sperm 
cells 
Oral (gavage) 200, 400 or 800 mg/kg bw Positive (Tian et al., 1992) 
 
Limited validity Non-validated test 
protocol. 
Micronucleus formation Mouse peripheral 
blood cells 
Gavage 1000, 2000 
3000 mg/kg bw 
Positive (Hiramoto et al., 1998) 
 
Valid. 
Micronucleus formation Male mice peripheral 
erythrocytes 
I.p. 500, 1000, 1500mg/kg bw Positive (Hiramoto et al., 
1996b) 
 
Valid. 
2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone [13.084] 
Micronucleus formation Mouse peripheral 
blood cells 
Gavage 0, 1000, 2000 and 3000 
mg/kg bw  
Positive (Hiramoto et al., 1998) 
 
Valid. 
Micronucleus formation Male mice peripheral 
erythrocytes 
I.p. 0, 500, 1000 and 1500 mg/kg 
bw 
Positive (Li et al., 1998) 
 
Valid. 
a: Validity of genotoxicity studies: 
 Valid. 
 Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation). 
 Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
 Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
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Table 2.3: ADDITIONAL GENOTOXICITY DATA (in vitro and in vivo) EFSA / FGE.220Rev1 (EFSA, 2011a)  
Chemical Name [FL-no]  Test System Test Object  Route Dose Reported Result  Reference  Comments a
4-Hydroxy-2,5-dimethylfuran-3(2H)-
one [13.010] 
Mouse Lymphoma L5178Ytk+/- mouse 
lymphoma cells 
- 111, 167, 250, 375 and 750 
µg/ml 
Negative both with and 
without S9 
(Ross and Harris, 1979a) Limited validity.  
Study not performed according to 
current guideline. To short treatment 
and no differentiation between small 
and large colonies. 
 
Dominant lethal assay in 
a rat fertility study 
Dominant lethals in 
Crl:CD(SD) male rats 
(25/group) 
Oral gavage 100, 500 and 1000 mg/kg 
bw/day for 2 weeks (Phase I) 
and 9 weeks (Phase II) 
No increase of dominant 
lethal effects 
(Sloter, 2008) Valid GLP study in accordance with 
ICH Guideline 4.1.1. 
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TABLE 3: SUMMARY OF SAFETY EVALUATIONS 
Table 3.1: Summary of Safety Evaluation of Furanone Derivatives (JECFA, 2006a; JECFA, 2009a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
13.084 
1449 
2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone 
O
OHO  
203 
13 
Class II 
A3: Intake below 
threshold 
4) Evaluted in FGE.220Rev1, 
genotoxicity concern could be 
ruled out. 
EFSA allocated the substance 
to Class III. 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
13.085 
1450 
4-Hydroxy-5-methylfuran-3(2H)-
one 
O
OHO  
47.8 
0.07 
Class II 
A3: Intake below 
threshold 
4) Evaluted in FGE.220Rev1, 
genotoxicity concern could be 
ruled out. 
EFSA allocated the substance 
to Class III. 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
13.099 
1456 
4-Acetoxy-2,5-dimethylfuran-
3(2H)-one 
O
OO
O
 
400 
8 
Class II 
A3: Intake below 
threshold 
4) Evaluted in FGE.220Rev1, 
genotoxicity concern could be 
ruled out. 
EFSA allocated the substance 
to Class III. 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
13.010 
1446 
4-Hydroxy-2,5-dimethylfuran-
3(2H)-one 
O
OHO  
4483 
5203 
Class II 
A3: Intake above 
threshold, A4: Not 
endogenous, A5: 
Adequate NOAEL exists 
4) Evaluted in FGE.220Rev1, 
genotoxicity concern could be 
ruled out. 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.176 
1519 
Furaneyl butyrate O
OO
O
 
4.2 
4 
Class III 
No evaluation 
 Evaluted in FGE.220Rev1, 
genotoxicity concern could be 
ruled out. 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to 4-Butyroxy-2,5-
dimethyl-3(2H)-furanone 
Flavouring Group Evaluation 99
 
EFSA Journal 2012;10(10):2901 
 
24
Table 3.1: Summary of Safety Evaluation of Furanone Derivatives (JECFA, 2006a; JECFA, 2009a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
(EFFA, 2012d).  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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ABBREVIATIONS 
BW  Body weight 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EFSA  The European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practise 
ID  Identity 
I.p.  Intraperitoneal 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NCE  Normochromatic erythrocyte 
No  Number 
NOAEL No observed adverse effect level 
NTP  National Toxicology Program 
OECD  Organisation for Economic Co-operation and Development 
PCE  Polychromatic erythrocyte 
(Q)SAR (Quantitative) Structure-Activity Relationship 
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SCE  Sister chromatic exchange 
SCF  Scientific Committee on Food 
WHO  World Health Organisation 
